MedTrace Logo

An Open Single Centre Study To Assess Treatment of Chronic Constipation in Children

NCT00403897 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 81

Last updated 2008-04-16

No results posted yet for this study

Summary

The purpose of this study was to evaluate the safety and efficacy of Movicol in the treatment of chronic constipation in children.

Conditions

  • Chronic Constipation

Interventions

DRUG

Polyethylene glycol 3350 Na bicarbonate NaCl KCl

6.9g sachet, oral

Sponsors & Collaborators

Principal Investigators

  • Winita Hardikar, MD · Royal Children's Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
24 Months
Max Age
11 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-08-31
Completion
2003-01-31

Countries

  • Australia

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00403897 on ClinicalTrials.gov